Minnesota Oncology Hematology PA-Minneapolis — Minneapolis, Minnesota

Minnesota Oncology Hematology PA-Minneapolis is a clinical research site located in Minneapolis, Minnesota, United States 55407.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology PA-Minneapolis has participated in 1 clinical trials.

Therapeutic areas: Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland Hurthle Cell Carcinoma.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology PA-Minneapolis?

Minnesota Oncology Hematology PA-Minneapolis has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology PA-Minneapolis conducted?

Minnesota Oncology Hematology PA-Minneapolis has 1 clinical trials on record. Their work covers Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland Hurthle Cell Carcinoma.

Is Minnesota Oncology Hematology PA-Minneapolis accredited by Crixeo Health?

Minnesota Oncology Hematology PA-Minneapolis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology PA-Minneapolis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.